Lineage, Inc. Common Stock (LINE)vsTwo Harbors Investments Corp (TWO)
LINE
Lineage, Inc. Common Stock
$39.96
-0.03%
REAL ESTATE · Cap: $10.02B
TWO
Two Harbors Investments Corp
$12.55
+1.37%
REAL ESTATE · Cap: $1.30B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 986% more annual revenue ($5.36B vs $493.78M). LINE leads profitability with a -2.7% profit margin vs -69.5%. TWO earns a higher WallStSmart Score of 51/100 (C-).
LINE
Hold39
out of 100
Grade: F
TWO
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.27
Current Price
$39.96
$121.31 discount
Intrinsic value data unavailable for TWO.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Revenue surging 1569.0% year-over-year
Strong operational efficiency at 27.6%
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
ROE of -1.8% — below average capital efficiency
Smaller company, higher risk/reward
Weak financial health signals
Expensive relative to growth rate
ROE of -17.7% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : TWO
The strongest argument for TWO centers on Price/Book, Revenue Growth, Operating Margin. Revenue growth of 1569.0% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : TWO
The primary concerns for TWO are Market Cap, Piotroski F-Score, PEG Ratio.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while TWO is a hypergrowth play — different risk/reward profiles.
TWO is growing revenue faster at 1569.0% — sustainability is the question.
TWO generates stronger free cash flow (56M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TWO scores higher overall (51/100 vs 39/100) and 1569.0% revenue growth. LINE offers better value entry with a 75.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Two Harbors Investments Corp
REAL ESTATE · REIT - MORTGAGE · USA
Two Harbors Investment Corp. The company is headquartered in Minnetonka, Minnesota.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?